This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Marco Preuss, Ph.D
Project Leader, Process Development, Bioconjugate at Lonza
Speaker

Profile

After earning a PhD in molecular design and complex assembly, Marco Preuss transitioned to industry and joined Lonza in early 2024 as Project Leader in Bioconjugates Process Development. He focuses on designing innovative, scalable, and manufacturable processes for antibody–drug conjugates and related modalities.

Agenda Sessions

  • A Holistic Approach to ADC Developability and Process Design – De-Risking Scale-Up Challenges

    13:45